山东大学耳鼻喉眼学报 ›› 2022, Vol. 36 ›› Issue (3): 245-255.doi: 10.6040/j.issn.1673-3770.0.2021.422

• 临床研究 • 上一篇    下一篇

新冠疫情期间基于门诊患者的变应性鼻炎患者比例构成分析

龚霄阳1,2,程雷1,2   

  1. 南京医科大学第一附属医院/江苏省人民医院 1. 耳鼻咽喉科;
    2.过敏诊疗中心, 江苏 南京 210029
  • 发布日期:2022-06-15
  • 通讯作者: 程雷. E-mail:chenglei@jsph.org.cn

Analysis of proportion of outpatients with allergic rhinitis during the coronavirus infectious disease 2019 pandemic

GONG Xiaoyang1,2, CHENG Lei1,2   

  1. 1. Department of Otorhinolaryngology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China;
    2. Department of Clinical Allergy Center, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China
  • Published:2022-06-15

摘要: 目的 探讨新型冠状病毒肺炎疫情期间基于门诊患者的变应性鼻炎(AR)患者比例构成,分析疫情期间与非疫情期间AR患者就诊人数的变化,讨论居家以及佩戴口罩对于AR发病的影响。 方法 收集2017-2020年每年3月、4月和5月在耳鼻咽喉科门诊就诊的患者总数,以及诊断为“变应性鼻炎”“过敏性鼻炎”“慢性鼻炎”的患者数量,分析鼻炎患者人次占门诊患者总数的比例构成,并进一步分层分析AR患者中不同性别、年龄的发病差异。 结果 2020年疫情期间3月、4月和5月鼻炎患者人次占门诊患者总数的比例,3月因患者较少可比性差,4月与2018年4月(P=0.028)、5月与2019年5月(P=0.001)同比差异具有统计学意义,其余时间同比差异无统计学意义(P均>0.05),但患者总数的峰值因疫情影响有所延后。AR患者中男性比例略高于女性,与往年同比差异无统计学意义。年龄方面0~18岁组AR患者比例高于往年,差异有统计学意义(P均<0.05);19~40岁组及41~60岁组与往年同比差异无统计学意义,>60岁组样本量较少,比例变化较大。2020年6月疫情平稳以后AR患者就诊人次逐步趋近甚至部分超越2017~2019年同期水平。 结论 2020年新冠疫情期间可能因口罩密封、疫情压力、室内过敏原以及室内空气条件等因素的影响,并未使AR患者占门诊患者总数的比例降低,甚至在疫情平稳后的一些月份与过去3年相比有轻微上升的趋势,提示佩戴口罩或居家隔离可能并未使AR的发病人数显著减少,但仍推荐AR患者出门时正确佩戴口罩,特别是花粉过敏者在致敏花粉播散期间外出,建议佩戴颗粒物防护口罩,需保持房间空气流通,并净化室内空气,以减轻AR相关症状。

关键词: 鼻炎, 变应性鼻炎, 新型冠状病毒肺炎, 门诊, 口罩

Abstract: Objective This study aimed to explore the proportion of outpatients with allergic rhinitis(AR)during the coronavirus infectious disease 2019(COVID-19)pandemic, analyze the relevant factors affecting the incidence of AR during the COVID-19 pandemic, and discuss the impact of staying indoors and wearing masks on the incidence of AR. Methods We collected data from the outpatients in the clinic of the Otolaryngology Department of Jiangsu Province Hospital in March, April, and May of 2017, 2018, 2019, and 2020 and total number of patients who were diagnosed with “AR,” and “chronic rhinitis.” We analyzed the proportion of patients with AR among the total number of patients, and further analyzed the differences in the incidence of AR by sex and age. Results The proportion of outpatients with AR in the total number of outpatients in March, April, and May before the COVID-19 pandemic in 2020 was statistically significant compared to that in April 2018(P=0.028)and May 2019(P=0.001)due to the low number of patients in March, while the differences in other months were not statistically significant. However, the peak of the total number of patients was delayed due to the impact of the COVID-19 pandemic. The proportion of male patients with AR was slightly higher than that of the female patients with AR, with no statistical significance compared to previous years. Regarding age, the proportion of patients with AR in the aged 0-18 years group was higher than that in previous years, and the difference was statistically significant(P<0.05). The aged 19-40years and 41-60 years groups showed no statistical significance compared to previous years, while the sample size of the aged >60 years group was limited and the proportion changed greatly. After the COVID-19 pandemic stabilized in June 2020, the visits of patients with AR gradually approached and partially exceeded the level of the same period from 2017 to 2019. Conclusions During the COVID-19 pandemic in 2020, the proportion of outpatients with AR in the total number of outpatients did not decrease due to factors, such as mask sealing problems, epidemic pressure, indoor allergens, and indoor air conditions, but slightly increased in some months after the COVID-19 pandemic stabilized compared to the past 3 years. Wearing masks and home quarantine did not significantly reduce the onset of the number of patients with AR, but it is still recommended in patients with AR to wear a face mask when going out, especially since pollen allergies during the sensitization pollen spread out, recommends wearing particulate respirators, keep the room ventilated, and purify indoor air, to alleviate AR-related symptoms.

Key words: Rhinitis, Allergic rhinitis, COVID-19, Outpatients, Masks

中图分类号: 

  • R765.22
[1] World Health Organization. Coronavirus disease(COVID-2019)situation reports[EB/OL].(https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/)
[2] Wu ZY, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019(COVID-19)outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention[J]. JAMA, 2020, 323(13): 1239-1242. doi:10.1001/jama.2020.2648.
[3] Greiner AN, Hellings PW, Rotiroti G, et al. Allergic rhinitis[J]. Lancet, 2011, 378(9809): 2112-2122. doi:10.1016/S0140-6736(11)60130-X.
[4] Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe[J]. Allergy, 2007, 62(Suppl 85): 17-25. doi:10.1111/j.1398-9995.2007.01549.x.
[5] Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma(ARIA)2008 update(in collaboration with the World Health Organization, GA(2)LEN and AllerGen)[J]. Allergy, 2008, 63(Suppl 86): 8-160. doi:10.1111/j.1398-9995.2007.01620.x.
[6] Wang XD, Zheng M, Lou HF, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011[J]. Allergy, 2016, 71(8): 1170-1180. doi:10.1111/all.12874.
[7] Ren JJ, Pang WD, Luo YX, et al. Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality[J]. J Allergy Clin Immunol Pract, 2022, 10(1): 124-133. doi:10.1016/j.jaip.2021.10.049.
[8] Yang JM, Koh HY, Moon SY, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study[J]. J Allergy Clin Immunol, 2020, 146(4): 790-798. doi:10.1016/j.jaci.2020.08.008.
[9] 宋岚. 花粉调查在花粉症防治中的必要性[J]. 现代预防医学, 2013, 40(2): 370-371, 375.
[10] 欧阳昱晖, 范尔钟, 李颖, 等. 春季花粉浓度对过敏性鼻炎患者的影响[J]. 中国耳鼻咽喉头颈外科, 2011, 18(12): 628-630. doi:10.16066/j.1672-7002.2011.12.011. OUYANG Yuhui, FAN Erzhong, LI Ying, et al. Effects of spring pollen concentration on allergic rhinitis subjects in Beijing[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2011, 18(12): 628-630. doi:10.16066/j.1672-7002.2011.12.011.
[11] 万远芳, 刁庆春. 法国梧桐花粉及其变应原研究进展[J]. 中国中西医结合皮肤性病学杂志, 2008, 7(2): 128-130. doi:10.3969/j.issn.1672-0709.2008.02.034.
[12] Yamamoto H, Yamada T, Sakashita M, et al. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis[J]. Allergy Asthma Proc, 2012, 33(2): e17-e22. doi:10.2500/aap.2012.33.3514.
[13] Tovey ER, Chapman MD, Platts-Mills TA. Mite faeces are a major source of house dust allergens[J]. Nature, 1981, 289(5798): 592-593. doi:10.1038/289592a0.
[14] 常生, 赵娟芝. 我国医用口罩标准对比解读[J]. 针织工业, 2020(3): 14-17. CHANG Sheng, ZHAO Juanzhi. Comparison and index analysis of medical mask standards in China[J]. Knitting Industries, 2020(3): 14-17.
[15] Lee SA, Hwang DC, Li HY, et al. Particle size-selective assessment of protection of European standard FFP respirators and surgical masks against particles-tested with human subjects[J]. J Healthc Eng, 2016:8572493. doi:10.1155/2016/8572493.
[16] He XJ, Reponen T, McKay R, et al. How does breathing frequency affect the performance of an N95 filtering facepiece respirator and a surgical mask against surrogates of viral particles? [J]. J Occup Environ Hyg, 2014, 11(3): 178-185. doi:10.1080/15459624.2013.848037.
[17] Dror AA, Eisenbach N, Marshak T, et al. Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic[J]. J Allergy Clin Immunol Pract, 2020, 8(10): 3590-3593. doi:10.1016/j.jaip.2020.08.035.
[18] Heinrich J. Influence of indoor factors in dwellings on the development of childhood asthma[J]. Int J Hyg Environ Health, 2011, 214(1): 1-25. doi:10.1016/j.ijheh.2010.08.009.
[19] Liu C, Zhang Y, Benning JL, et al. The effect of ventilation on indoor exposure to semivolatile organic compounds[J]. Indoor Air, 2015, 25(3): 285-296. doi:10.1111/ina.12139.
[20] Piekarska B, Furmańczyk K, Jaworski S, et al. Building age, type of indoor heating and the occurrence of allergic rhinitis and asthma[J]. Postepy Dermatol Alergol, 2020, 37(1): 81-85. doi:10.5114/ada.2019.85288.
[21] Duan J, Wang X, Zhao DS, et al. Risk effects of high and low relative humidity on allergic rhinitis: time series study[J]. Environ Res, 2019, 173: 373-378. doi:10.1016/j.envres.2019.03.040.
[22] Li YS, Hu HS, Zhang T, et al. Increase in indoor inhalant allergen sensitivity during the COVID-19 pandemic in South China: a cross-sectional study from 2017 to 2020[J]. J Asthma Allergy, 2021, 14: 1185-1195. doi:10.2147/JAA.S322034.
[23] 袁峰. 影响变应性鼻炎发病及预后的相关危险因素Logistic回归分析[J]. 中国耳鼻咽喉颅底外科杂志, 2017, 23(3): 266-270. doi:10.11798/j.issn.1007-1520.201703017. YUAN Feng. Logistic regression analysis of risk factors affecting the incidence and prognosis of allergic rhinitis[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2017, 23(3): 266-270. doi:10.11798/j.issn.1007-1520.201703017.
[24] Kwon JA, Lee M, Yoo KB, et al. Does the duration and time of sleep increase the risk of allergic rhinitis? Results of the 6-year nationwide Korea youth risk behavior web-based survey[J]. PLoS One, 2013, 8(8): e72507. doi:10.1371/journal.pone.0072507.
[25] Rhee CS, Wee JH, Ahn JC, et al. Prevalence, risk factors and comorbidities of allergic rhinitis in South Korea: the Fifth Korea National Health and Nutrition Examination Survey[J]. Am J Rhinol Allergy, 2014, 28(2): e107-e114. doi:10.2500/ajra.2014.28.4040.
[26] Osman M. Therapeutic implications of sex differences in asthma and atopy[J]. Arch Dis Child, 2003, 88(7): 587-590. doi:10.1136/adc.88.7.587.
[27] 梁慧敏, 汪李琴, 万文锦, 等. 耳鼻咽喉科内镜室新型冠状病毒感染防控方案的探讨与实践[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 88-92. doi:10.6040/j.issn.1673-3770.0.2020.078. LIANG Huimin, WANG Liqin, WAN Wenjin, et al. COVID-19 prevention and control scheme in an ENT endoscopy unit in China[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(2): 88-92. doi:10.6040/j.issn.1673-3770.0.2020.078.
[1] 吕倩,唐源,顾子君,施赛磊,刘萍,万文锦. 变应性鼻炎患者疾病获益感现状及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 21-28.
[2] 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[3] 秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[4] 杜康丽,郑振宇,徐战将,张宇,陈露,卢梦垚. 鼻中隔偏曲并发慢性鼻窦炎风险预测模型的构建与验证[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 78-86.
[5] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[6] 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[7] 黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41.
[8] 刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[9] 张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[10] 张竹萍,彭孜灿,肖振龙,李程,喻迪,王兴龙,陈伟,郭蓓. 新型鼻分泌物嗜酸粒细胞阳离子蛋白-髓过氧化物酶试纸在变应性鼻炎中的应用价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 129-134.
[11] 刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[12] 杨娟娟,郎永耀,周文成. 孕妇分娩前后鼻眼部症状变化规律分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 59-64.
[13] 周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[14] 王曼娴,郑泉,杨亮. 细菌裂解物治疗变应性鼻炎的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 141-145.
[15] 刘畅,方宏艳,刘敩,富东娜,王贺,王晶,杨景朴. 长春地区秋季变应性鼻炎蒿属花粉致敏特征分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 13-19.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!